M. A. Jackson, M. R. Holland, J. Nicholas, R. Lodwick, D. Forster and I. A. Macdonald, “Hemodialysis-Induced Hypoglycemia in Diabetic Patients,” Clinical Nephrology, Vol. 54, No.1, 2000, pp. 30-34.
 R. A. Ward, R. L. Wathen, T. E. Williams and G. B. Harding, “Hemodialysate Composition and Intradialytic Metabolic, Acid-Base and Potassium Changes,” Kidney International, Vol. 32, 1987, pp. 129-135. doi:10.1038/ki.1987.182
 A. Gutierrez, J. Bergstrom and A. Alvestrand, “Hemodialysis-Associated Protein Catabolism with and without Glucose in the Dialysis Fluid,” Kidney International, Vol. 46, 1994, pp. 814-822. doi:10.1038/ki.1994.337
 C. L. Skutches and M. H. Sigler, “Plasma Glucose Turn-over and Oxidation during Hemodialysis: Nutritional Effect of Dialysis Fluid,” American Journal of Clinical Nutrition, Vol. 65, No. 1, 1997, pp. 128-135.
 S. F. Raju, A. R. White, T. T., Barnes P. P. Smith and K. A. Kirchner, “Improvement in Disequilibrium Symptoms during Dialysis with Low Glucose Dialyzate,” Clinical Nephrology, Vol. 18, No. 3, 1982, pp. 126-129.
 G. Ramirez, B. L. Bercaw, D. E. Butcher, H. L. Mathis, C. Brueggemeyer and J. L. Newton, “The Role of Glucose in Hemodialysis: The Effects of Glucose-Free Dialysate,” American Journal of Kidney Diseases, Vol. 7, No. 5, 1986, pp. 413-420.
 M. Sangill and E. B. Pedersen, “The Effect of Glucose Added to the Dialysis Fluid on Blood Pressure, Blood Glucose and Quality of Life in Hemodialysis Patients: A Placebo Controlled Cross-Over Study,” American Journal of Kidney Diseases, Vol. 47, No. 4, 2006, pp. 636-643. doi:10.1053/j.ajkd.2006.01.007
 R. A. DeFronzo, J. D. Tobin, J. W. Rowe and R. Andres, “Glucose Intolerance in Uremia. Quantification of Pancreatic Beta Cell Sensitivity to Glucose and Tissue Sensitivity to Insulin,” Journal of Clinical Investigation, Vol. 62, 1978, pp. 425-435. doi:10.1172/JCI109144
 E. B. Pedersen, H. Eiskjaer, B. Madsen, H. Danielsen, M. Egeblad and C. B. Nielsen, ”Effect of Captopril on Renal Extraction of Renin, Angiotensin II, Atrial Natriuretic Peptide and Vasopressin, and Renal Vein Renin Ratio In Patients with Arterial Hypertension and Unilateral Renal Artery Disease,” Nephrology Dialysis Transplantation, Vol. 8, No. 10, 1993, pp. 1064-1070.
 D. Haffner, F. Schaefer, J. Girard, E. Ritz and O. Mehls, “Metabolic Clearance of Recombinant Human Growth Hormone in Health and Chronic Renal Failure,” Journal of Clinical Investigation, Vol. 93, No. 3, 1994, pp. 1163-1171. doi:10.1172/JCI117069
 J. D. Veldhuis, A. Iranmanesh, M. J. Wilkowski and E. Samojlik, “Neuroendocrine Alterations in the Somatotropic and Lactotropic Axes in Uremic Men,” European Journal of Endocrinology, Vol. 131, No. 5, 1994, pp. 489-498. doi:10.1530/eje.0.1310489
 V. Allegra, F. Amendolagine, G. Mengozzi, M. Tenti and A. Vasile, “Growth Hormone Secretion Abnormalities in Uremic Patients: Which Is the Role of Impaired Glucose Hypothalamic Sensitivity?” Nephron, Vol. 48, No. 1, 1988, pp. 76-77. doi:10.1159/000184874